I'm trying to get a handle on a very slippery timeline. My
I'm trying to get a handle on a very slippery timeline. My guess timeline is 2 to 5 years. Can anyone venture an educated guess on settlement with Amarex or parent company. I ask only because from my past experience they can outlast us simply by delaying the process and make us run out of money. GE did it to Tesla and got the patents on AC to boot and it's not that hard to do if you have staying power. I would like to hear from anyone with legal background or prior experience in these type of litigation's.
We have limited time and money raising opportunities at this point. Getting a partner or approval may save us but if it doesn't happen within this year, my personal timeline of this molecule being a success with Cytodyn seems to go into reverse mode. I have been an avid supporter for 4 years now and have invested way over my allotment because of Nader and possible my nature of being a chance taker in the bio market. Knowing this economy is going to continually punish companies with negative earnings going forward for possibly the next 2 years even if they have a great story, is partially my reasoning for this musing. Earnings seems to be the key and the company has to somehow make that happen. Even if it means making deals that seem fortuitous to the larger company for the time being, I think it is the way forward. Continually selling stock has kept the doors open but at some point real soon, it will make the company worthless, especially to older shareholders who can't keep putting money into lower their SP when there can be potentially a billion shares out there and an extending timeline.
I'm not raising a red flag, more of a warning shot to the mgmt...make a deal before the ship runs aground and we all scatter like roaches to the next greatest thing with our tails between our legs and a very expensive lesson.
Is this next announcement important? you bet your ass it is! The reason Cytodyn has not updated us is...they have no concrete info that will move the SP positively and know it. They understood salesman speak has worn out everyone and pure definable results are the only meter to go by. The results next week will determine to a large extent if a breath of hope is there to partner in my estimation. The molecule has many optimistic areas of research but few takers. That almost always means the large companies that are interested are waiting like vultures and will do all they can to make sure it comes within millimeters of death before swooping down to scoop it up at nothing prices. They obviously don't have confidence that the mgmt can steer the company long enough to win the war and are content to let them flounder until they die (knowing they have a partner in the FDA with their foot on our neck) and take many of us investors down with them. This intern allows their competing drugs to flourish while ours dies. It's a win win for the acquiring company. Unfortunately I have seen this in a few investments throughout my years and am starting to see the writing on the wall once again. I am hoping next week brings not only good factual results that blow away the competition but also a partnership announcement. Sorry for the long disjointed post but almost $1,000,000 invested and peanuts to show has made me active and short tempered to say the least.
Ok, I'm done for the year. Moderators, you may delete this post but I felt the need to get it out. Whew!
12
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Local Impact Means Taking Climate Change Personally If you haven't felt it yet, you will. Climate change isn't just a global headline anymore—it's a daily reality that’s reshaping life where you stand. David W. DuBois, New Mexico's top climatologist, is sounding the alarm this time on the new Net Zero Speaks episode, saying it's on us to use local climate knowledge to...
Continue Reading
IFA Unveils a Game-Changer for Senior Living Imagine having a helper at home that not only looks out for your safety but also keeps you company. That's exactly what Tuya Smart's new AI creation, Doova, is set to do. Unveiled at the IFA 2026, Doova isn't just another gadget—it’s a big leap for folks choosing to live out their golden years independently. Navigating...
Continue Reading
Frederick’s Local Scene Takes the Spotlight Ever strolled down a street and felt the neighborhood pulse through your bones? That vibe—you know it if you've been to Frederick, Maryland. And that very essence is captured in the latest edition of Sass Magazine's LOCAL issue. This isn't just your garden-variety publication; it's a window into the heart of Frederick...
Continue Reading
York Space Systems: Under Legal Fire You ever hear the one about York Space Systems? Yeah, their ticker YSS is buzzing for all the wrong reasons. Not even a year out from their IPO, and already they're tangled in a class action lawsuit that's got investors with their heads in their hands. ClaimsFiler, a shareholder information outfit, just blasted out a reminder for...
Continue Reading
AI Taking Center Stage at IFA 2026 Amidst the chaos of tech exhibitions, something caught my attention—Tuya Smart's push in making AI a household name. Now, you might wonder why I’m bringing this up. Well, because it's not your typical flashy gadget talk. This is about Tuya parading their latest breakthroughs like a peacock at the world's stage, IFA 2026 in Berlin,...
Continue Reading
A New Chapter in Home Robotics In today's tech-centric world, newcomers often confuse flash with substance. But every now and then, you catch a glimpse of something that might just change how the world spins. At this year's IFA 2026, PrimeBOT didn't just dip its toes into the limelight—it cannonballed right in, drumming up some serious buzz with its PrimeBOT T1 and...
Continue Reading
Pushing Forward Yet Stumbling on the Details We've got a fresh scoop from the AI Leaders Council: They just rolled out their 2026 Corporate AI Talent Study. What's the big fuss? Well, they're tracking how companies are cozying up to artificial intelligence. Let's just say it's a mixed bag this time around. While almost everyone jumped on the AI bandwagon, only a scant 3%...
Continue Reading
Building Bridges Through Community Investment Well, ain't this something? Columbia, Tennessee, just got a splash of fresh air. We're talking about the new Southern Regional Technology Center nested in Columbia State Community College. Now, the name on everyone's lips? The TriStar Bank Community Room. But it ain't just about a name plastered up on a wall inside a shiny...
Continue Reading
Revving Up for the European Cycling Scene There's something about the open road and the whirr of wheels that gets blood pumping—maybe it's the competition, maybe it's the gear. Either way, this year's Italian Bike Festival is turning the Misano World Circuit into a battleground for cycling's elite, with evolve and ELITEWHEELS charging at the forefront. They're not just...
Continue Reading
Leadership, Innovation, and Soccer Collide in Berlin When you’ve got a Barcelona legend like Carles Puyol gracing an event, it's more than just fanfare. This time around, Puyol made waves at Midea's stand during IFA 2026 in Berlin, signaling a strategic power move for both Midea and FC Barcelona. We're talking about a scene where tech innovation meets world-class...
Continue Reading
Top 5 Most Recently Viewed Articles
Investigation Launched into The Toronto Dominion Bank In a significant development, Bronstein, Gewirtz & Grossman, LLC has initiated an investigation concerning The Toronto Dominion Bank (NYSE: TD). This comes in light of serious allegations, and the firm is reaching out to investors for assistance. Background on the Investigation The investigation stems from the recent...
Continue Reading
Thunder Bridge IV and Coincheck Prepare for a Transformative Merger Thunder Bridge Capital Partners IV, Inc. is stepping into an exciting new phase as it moves forward with its proposed merger with Coincheck, Inc., a notable player in the cryptocurrency trading sector. Known for its extensive reach and innovative technology, Coincheck is on a mission to transform the...
Continue Reading
Transforming E-Commerce: A New Era for Retail Exchange Solutions, a forefront leader in AI-powered customer engagement solutions, has joined forces with Bealls Inc. This partnership seeks to revolutionize e-commerce and enhance customer interactions dramatically. By deploying the innovative ES Engage™ platform, Bealls Inc. is set to experience extraordinary growth in...
Continue Reading
Introducing Cachorrisimo In a world where pet nutrition is evolving, Cachorrisimo emerges as a pioneering dog food brand that harmoniously blends health, nutrition, and cultural heritage. Founded by Diego Rondon, this brand encapsulates the essence of family, food, and the rich flavors of Hispanic traditions. With a personal touch inspired by his dog, Milo, Rondon sought...
Continue Reading
Important Earnings Announcement from Under Armour Under Armour, Inc. (NYSE: UA, UAA) is gearing up to share its financial results for the second quarter of fiscal 2026, covering the period that ended on September 30, 2025. This eagerly awaited report is scheduled for release on November 6, 2025. Investors and analysts alike are keen to learn about the company’s...
Continue Reading